Literature DB >> 27746440

Recurrent Cholangitis in a Patient with Autosomal Dominant Polycystic Kidney Disease (ADPKD) and Caroli's Disease.

Eiko Hasegawa1, Naoki Sawa, Junichi Hoshino, Tatsuya Suwabe, Noriko Hayami, Masayuki Yamanouchi, Akinari Sekine, Rikako Hiramatsu, Aya Imafuku, Masahiro Kawada, Yoshifumi Ubara, Tsunao Imamura, Kenmei Takaichi.   

Abstract

We herein present a rare case of an autosomal dominant polycystic kidney disease (ADPKD) patient with Caroli's disease, a congenital embryonic biliary tree ductal plate abnormality often associated with autosomal recessive polycystic kidney disease. A 76-year-old woman with ADPKD on hemodialysis was admitted to our hospital with recurrent cholangitis and hepatobiliary stones. Caroli's disease was diagnosed according to typical imaging findings of cystic intrahepatic bile duct dilatation and the central dot sign. Hepatobiliary system abnormalities such as Caroli's disease should be considered in febrile ADPKD patients, even in the absence of typical clinical signs or symptoms.

Entities:  

Mesh:

Year:  2016        PMID: 27746440      PMCID: PMC5109570          DOI: 10.2169/internalmedicine.55.6818

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


Introduction

Autosomal dominant polycystic kidney disease (ADPKD) is an inherited disorder mainly associated with renal cyst formation and renal function deterioration. Intrahepatic cysts are the most common hepatic complication of ADPKD (1). Caroli's disease was first described in 1958 (2). As originally reported, the entity is characterized by: 1) segmental cystic dilatation of the intrahepatic bile ducts; 2) high incidence of intrahepatic cholelithiasis, cholangitis, and hepatic abscesses; 3) absence of cirrhosis and portal hypertension; and 4) association with renal tubular ectasia or medullary sponge kidney and, in some instances, pancreatic cysts. The combination of Caroli's disease and congenital hepatic fibrosis is commonly known as Caroli's syndrome. Caroli's disease or syndrome is often associated with autosomal recessive polycystic kidney disease (ARPKD), but it is a rare complication of ADPKD. Only four case reports describing ADPKD associated with Caroli's disease or syndrome have previously been published (3-6). Renal and hepatic cyst infections are the major causes of a fever in ADPKD patients (7). Infection of the hepatobiliary tract has also been reported to occur in ADPKD patients with hepatobiliary morphologic abnormalities. We herein report a rare case of ADPKD with Caroli's disease and recurrent hepatobiliary infection. The study of this case was approved by the institutional review board of Toranomon Hospital.

Case Report

A 76-year-old woman was admitted to our hospital for the evaluation of an intractable fever with chills in August 2012. ADPKD had been diagnosed in 1982, and hemodialysis treatment was started in 1998. Transcutaneous renal arterial embolization was performed to reduce abdominal distension related to enlarged kidneys in 2007 (8). A clipping operation was carried out for left anterior cerebral artery aneurysm in 2008. One of her two daughters was also diagnosed with ADPKD. The patient had presented with a high fever and bacteremia once or twice per year since 2009, and renal or hepatic cyst infection was considered to be causative on each occasion. On this admission, the patient was 150.3 cm tall and weighed 54.7 kg, with a blood pressure of 138/61 mmHg and a temperature of 38.3℃. A physical examination revealed no jaundice or abdominal tenderness. The results of the laboratory examination are shown in Table. Regarding enzymes related to hepatobiliary tract diseases, only alkaline phosphatase (ALP) was increased slightly. The C-reactive protein concentration was 2.7 mg/dL. A blood culture was positive for extended-spectrum β-lactamase-producing Escherichia coli (ESBL-E. coli). Magnetic resonance imaging (MRI) indicated multiple large renal cysts consistent with ADPKD and multiple hepatic cysts located mainly in peribiliary regions (Fig. 1a). There were no signs of cyst infections on MRI, such as an increased intensity on diffusion-weighted imaging, niveau, wall thickening, or gas in the cysts, which we previously reported to be typical findings of infected cysts (9). MRI revealed a common bile duct stone and cystic dilatation of the intrahepatic bile ducts in the left lobe (Fig. 1b). No gallbladder stones were observed. Contrast-enhanced abdominal computed tomography (CT) showed the central dot sign representing the fibrovascular bundle within the dilated cystic intrahepatic ducts (Fig. 2), which was considered to be characteristic feature of Caroli's disease (10). Endoscopic retrograde cholangiography (ERC) also demonstrated cystic dilated biliary ducts with stones (Fig. 3). One black stone suggesting bilirubin origin was removed under ERC, but unremovable stones existed. ESBL-E. coli was also detected in the bile culture. According to these findings, recurrent cholangitis related to Caroli's disease with bile duct stones was diagnosed.
Table.

Laboratory Data on Admission to the Hospital.

hemoglobin8.4(11.3-15.0)g/dL
White blood cells5,200(3.2-7.9)/µL
platelets18.5×104(15.5-35.0)/µL
total protein6.9(6.9-8.4)g/dL
albumin2.7(3.9-5.2)g/dL
urea nitrogen29(8-21)mg/dL
creatinine5.4(0.46-0.78)mg/dL
alkaline phosphatase492(117-350)IU/L
gamma glutamyl transferase31(9-109)IU/L
alanine aminotransferase4(8-40)IU/L
aspartate aminotransferase15(13-33)IU/L
total bilirubin0.5(0.3-1.1)mg/dL
C-reactive protein2.7(<0.3)mg/dL
Figure 1.

(a) Magnetic resonance imaging (MRI) indicated multiple large renal cysts consistent with ADPKD and multiple hepatic cysts located mainly in peribiliary regions. (b) MRI revealed cystic dilatation of the intrahepatic bile ducts in the left lobe and peribiliary cysts.

Figure 2.

Contrast-enhanced abdominal CT showed the central dot sign (circle), representing the fibrovascular bundle (arrow) within the dilated cystic intrahepatic ducts, which is considered to be a characteristic feature of Caroli's disease.

Figure 3.

Endoscopic retrograde cholangiography (ERC) demonstrated cystic dilated biliary ducts with stones.

Laboratory Data on Admission to the Hospital. (a) Magnetic resonance imaging (MRI) indicated multiple large renal cysts consistent with ADPKD and multiple hepatic cysts located mainly in peribiliary regions. (b) MRI revealed cystic dilatation of the intrahepatic bile ducts in the left lobe and peribiliary cysts. Contrast-enhanced abdominal CT showed the central dot sign (circle), representing the fibrovascular bundle (arrow) within the dilated cystic intrahepatic ducts, which is considered to be a characteristic feature of Caroli's disease. Endoscopic retrograde cholangiography (ERC) demonstrated cystic dilated biliary ducts with stones. Sepsis was controlled with intravenous meropenem, however, the fever recurred when the treatment was changed to oral antibiotics, as shown in Fig. 4. The patient exhibited febrile episodes five times within a year due to cholangitis, liver abscess, or hepatic cyst infection. Since September 2013, the patient has received intravenous meropenem treatment at every hemodialysis session and cholangitis has been controlled since that time.
Figure 4.

Clinical course of the present case.

Clinical course of the present case.

Discussion

The presence of Caroli's disease or syndrome has previously been described in conjunction with ARPKD, which usually has a childhood onset. The association of Caroli's disease with ADPKD is rare (3-6). Both Caroli's disease and hepatic cysts in ADPKD are regarded as fibrocystic liver diseases, which comprise a group of congenital disorders resulting from ductal plate malformation, i.e., abnormal embryogenesis of the biliary ductal system (11). A ductal plate is defined as a cylindrical layer of cells that surrounds a branch of the portal vein and develops during the first week of gestation (12). The clinicopathological abnormality of fibrocystic liver disease is dependent on the level of the biliary tree affected during embryogenesis. The involvement of large intra-hepatic ducts results in Caroli's disease. ADPKD represents ductal plate malformation of medium-sized intrahepatic ducts. Small-sized intra-hepatic duct involvement results in congenital hepatic fibrosis. The disease entities can exist as individual conditions or in combination (11,13). A mutation in PKD1 encoding polycystin-1 or PKD2 encoding polycystin-2 gives rise to ADPKD. The identified gene underling ARPKD is PKHD1 encoding fibrocystin (14). These proteins localize to primary cilia of renal tubule cells and cholangiocytes (15). Although the hepatic phenotype of Caroli's disease generally appears in ARPKD, the phenotype of Caroli's disease was observed in ADPKD patient in the present case. Hepatic phenotype variants have been previously reported in ADPKD patients. Dranssart et al. observed intrahepatic bile duct abnormalities in 25 of 90 ADPKD patients (27.8%) with magnetic resonance cholangiography, which were correlated with hepatobiliary infection (16). Ishikawa et al. reported that common bile duct dilatation occurred more frequently in ADPKD patients than in non-ADPKD patients (17). Terada et al. examined specimens from autopsied livers and biliary tracts of three patients with ADPKD using intrahepatic cholangiography and found nonobstructive dilatation of the intrahepatic bile ducts in all cases (18). Jordon et al. reported the 17-year history of an ADPKD patient with a recurrent fever of unknown origin that was later attributed to Caroli's disease with multiple episodes of cholangitis (4). These phenotypic variants might be due to differences in the type or locus of the mutation of responsive genes, epigenetic mechanisms, and/or environmental factors (19). Our case presented with a recurrent fever and septicemia for several years. At first, renal or hepatic cyst infections were thought to be the cause of the fevers, because they are the most common causes of a fever in ADPKD (7). However, diagnostic imaging findings revealed the characteristic hepatobiliary abnormalities of Caroli's disease that lead to recurrent cholangitis with hepatobiliary stones. The patient did not present with abdominal pain, and her laboratory findings did not indicate liver function abnormality, except for a slight elevation of ALP. The treatment of Caroli's disease is largely supportive and should be individualized (20). Cholangitis and sepsis should be treated with appropriate antibiotics and biliary stone extraction whenever feasible. Partial hepatectomy may be curative in rare patients in whom the disease is confined to a single lobe of the liver (21). Patients who have recurrent bouts of biliary infection, particularly those who also have complications related to portal hypertension, may require liver transplantation (22). In the present case, it was difficult to choose surgical intervention because of the patient's old age and general condition. The prognosis is variable depending upon the severity of disease and the presence of coexisting renal dysfunction. Recurrent infections and other complications related to biliary lithiasis can be associated with significant morbidity. We herein experienced the rare case of an ADPKD patient with Caroli's disease. In conclusion, when we encounter intractable bacterial infection in ADPKD patients, we have to consider cholangitis related to abnormalities of hepatobiliary systems, such as Caroli's disease, as well as cyst infection.
  21 in total

Review 1.  Congenital diseases of intrahepatic bile ducts: variations on the theme "ductal plate malformation".

Authors:  V J Desmet
Journal:  Hepatology       Date:  1992-10       Impact factor: 17.425

2.  Caroli disease patients have excellent survival after liver transplant.

Authors:  Theresa R Harring; N Thao T Nguyen; Hao Liu; John A Goss; Christine A O'Mahony
Journal:  J Surg Res       Date:  2012-04-29       Impact factor: 2.192

3.  Caroli's disease: liver resection and liver transplantation. Experience in 33 patients.

Authors:  Woubet Tefera Kassahun; Thomas Kahn; Christian Wittekind; Joachim Mössner; Karel Caca; Johann Hauss; Peter Lamesch
Journal:  Surgery       Date:  2005-11       Impact factor: 3.982

4.  [Non-obstructive congenital dilatation of intrahepatic segmentary bile ducts (caroli's disease). Report of a case and review of the literature].

Authors:  J Berenguer; V Olaso; M Rayón; G Gordo; J Ruíz-Alonso; J Carrasq'uer; J Baguena
Journal:  Rev Clin Esp       Date:  1976-03-31       Impact factor: 1.556

5.  Caroli disease: central dot sign in CT.

Authors:  B I Choi; K M Yeon; S H Kim; M C Han
Journal:  Radiology       Date:  1990-01       Impact factor: 11.105

6.  Caroli's disease and autosomal dominant polycystic kidney disease: a rare association?

Authors:  C Mousson; M Rabec; J P Cercueil; J S Virot; P Hillon; G Rifle
Journal:  Nephrol Dial Transplant       Date:  1997-07       Impact factor: 5.992

7.  MR cholangiography in the evaluation of hepatic and biliary abnormalities in autosomal dominant polycystic kidney disease: study of 93 patients.

Authors:  Marie Dranssart; Francois Cognet; Christiane Mousson; Jean Pierre Cercueil; Gerard Rifle; Denis Krause
Journal:  J Comput Assist Tomogr       Date:  2002 Mar-Apr       Impact factor: 1.826

8.  Congenital biliary dilatation in autosomal dominant adult polycystic disease of the liver and kidneys.

Authors:  T Terada; Y Nakanuma
Journal:  Arch Pathol Lab Med       Date:  1988-11       Impact factor: 5.534

Review 9.  Genetic kidney diseases.

Authors:  Friedhelm Hildebrandt
Journal:  Lancet       Date:  2010-04-10       Impact factor: 79.321

Review 10.  ARPKD and early manifestations of ADPKD: the original polycystic kidney disease and phenocopies.

Authors:  Carsten Bergmann
Journal:  Pediatr Nephrol       Date:  2014-03-01       Impact factor: 3.714

View more
  3 in total

1.  Biliary Tract and Liver Complications in Polycystic Kidney Disease.

Authors:  Parminder K Judge; Charlie H S Harper; Benjamin C Storey; Richard Haynes; Martin J Wilcock; Natalie Staplin; Raph Goldacre; Colin Baigent; Jane Collier; Michael Goldacre; Martin J Landray; Christopher G Winearls; William G Herrington
Journal:  J Am Soc Nephrol       Date:  2017-05-02       Impact factor: 10.121

Review 2.  Pathogenesis of Choledochal Cyst: Insights from Genomics and Transcriptomics.

Authors:  Yongqin Ye; Vincent Chi Hang Lui; Paul Kwong Hang Tam
Journal:  Genes (Basel)       Date:  2022-06-08       Impact factor: 4.141

3.  Hepatointestinal complications in polycystic kidney disease.

Authors:  Shih-Ting Huang; Ya-Wen Chuang; Tung-Min Yu; Cheng-Li Lin; Long-Bin Jeng
Journal:  Oncotarget       Date:  2017-09-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.